CLL | Tumor

CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.

Brukinsa Shows Favorable Safety Profile Over Imbruvica in CLL

February 21st 2025, 8:00pm

Article

Researchers have found Brukinsa to be a potentially safer alternative for patients with chronic lymphocytic leukemia.

Why Hope is Important For Patients with Chronic Lymphocytic Leukemia

January 31st 2025, 6:00pm

Article

Hope is crucial for those of us with chronic lymphocytic leukemia, or any cancer, helping us navigate the disease's challenges.

Brukinsa May Improve Efficacy Versus Imbruvica in R/R CLL and SLL

January 28th 2025, 7:59pm

Article

Brukinsa had a lower risk of disease progression or death versus Imbruvica, as well as a more favorable safety profile, in R/R CLL and SLL.

Waiting for Results After My CLL Diagnosis

January 20th 2025, 6:00pm

Article

Waiting for results of a CT scan after a cancer diagnosis is agonizing, as I anxiously await news on whether my disease has returned.

Learning to ‘Let it Be’ After Poor Test Results

January 10th 2025, 6:00pm

Article

When I recognize my frustration and dissapointment with the test results for my chronic lymphocytic leukemia, I find comfort in listening to music.

Preparing for Treatment: A Personal Reflection on Cancer

December 31st 2024, 6:00pm

Article

As I prepare for treatment of my chronic lymphocytic leukemia, I reflect on the challenges of aging and side effects while staying focused on living fully.

Top Contributor Stories from 2024

December 30th 2024, 4:00pm

Article

Throughout the year, CURE® contributors shared personal stories and reflections highlighting the multifaceted nature of cancer care.

Top 4 Stories From the 2024 ASH Annual Meeting

December 24th 2024, 4:00pm

Article

CURE® highlights some top stories from the ASH Annual Meeting, focusing on B-cell acute lymphoblastic leukemia, multiple myeloma and other blood cancers.

Epkinly Leads to Responses in Heavily Pretreated Patients With CLL

December 23rd 2024, 2:00pm

Article

Among patients with heavily pretreated chronic lymphocytic leukemia, treatment with Epkinly monotherapy showed deep responses.

Imbruvica-Venetoclax Shows Promise in Managing CLL

December 18th 2024, 2:00pm

Article

A combination of Imbruvica and venetoclax showed significantly prolonged progression-free survival in patients with untreated CLL, an expert explained.